Given these promising results and a strong scientific rationale, combined with LX-101’s novel mechanism of action and prior positive clinical experience in oncology, Lirum is planning new clinical ...
Rekor Systems, Inc. (NASDAQ: REKR), a global leader in roadway intelligence, today provided insights into its preliminary year-end 2024 results and recent actions to improve financial performance by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback